Integra Lifesciences Holdings Corp (IART)
28.34
-0.07
(-0.25%)
USD |
NASDAQ |
Apr 26, 16:00
28.34
0.00 (0.00%)
After-Hours: 19:44
Integra Lifesciences Holdings Enterprise Value: 3.424B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.424B |
| April 24, 2024 | 3.500B |
| April 23, 2024 | 3.500B |
| April 22, 2024 | 3.468B |
| April 19, 2024 | 3.445B |
| April 18, 2024 | 3.677B |
| April 17, 2024 | 3.701B |
| April 16, 2024 | 3.692B |
| April 15, 2024 | 3.710B |
| April 12, 2024 | 3.769B |
| April 11, 2024 | 3.796B |
| April 10, 2024 | 3.869B |
| April 09, 2024 | 3.911B |
| April 08, 2024 | 3.898B |
| April 05, 2024 | 3.863B |
| April 04, 2024 | 3.847B |
| April 03, 2024 | 3.855B |
| April 02, 2024 | 3.825B |
| April 01, 2024 | 3.920B |
| March 28, 2024 | 3.977B |
| March 27, 2024 | 3.928B |
| March 26, 2024 | 3.843B |
| March 25, 2024 | 3.816B |
| March 22, 2024 | 3.844B |
| March 21, 2024 | 3.897B |
| Date | Value |
|---|---|
| March 20, 2024 | 3.872B |
| March 19, 2024 | 3.888B |
| March 18, 2024 | 3.882B |
| March 15, 2024 | 3.918B |
| March 14, 2024 | 3.930B |
| March 13, 2024 | 4.003B |
| March 12, 2024 | 4.011B |
| March 11, 2024 | 4.037B |
| March 08, 2024 | 4.063B |
| March 07, 2024 | 4.014B |
| March 06, 2024 | 4.015B |
| March 05, 2024 | 4.050B |
| March 04, 2024 | 4.001B |
| March 01, 2024 | 4.006B |
| February 29, 2024 | 4.078B |
| February 28, 2024 | 4.215B |
| February 27, 2024 | 4.653B |
| February 26, 2024 | 4.642B |
| February 23, 2024 | 4.687B |
| February 22, 2024 | 4.696B |
| February 21, 2024 | 4.689B |
| February 20, 2024 | 4.724B |
| February 16, 2024 | 4.711B |
| February 15, 2024 | 4.689B |
| February 14, 2024 | 4.603B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.424B
Minimum
Apr 25 2024
7.711B
Maximum
Apr 27 2021
5.734B
Average
5.745B
Median
Nov 30 2020
Enterprise Value Benchmarks
| Stryker Corp | 138.15B |
| OraSure Technologies Inc | 97.76M |
| Insulet Corp | 12.19B |
| PROCEPT BioRobotics Corp | 2.459B |
| Perspective Therapeutics Inc | 931.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 19.83M |
| Revenue (Quarterly) | 397.04M |
| Total Expenses (Quarterly) | 360.99M |
| EPS Diluted (Quarterly) | 0.25 |
| Gross Profit Margin (Quarterly) | 57.05% |
| Profit Margin (Quarterly) | 5.00% |
| Earnings Yield | 2.93% |
| Operating Earnings Yield | 4.90% |
| Normalized Earnings Yield | 2.929 |